Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Weighted average diluted shares outstanding
3Y CAGR
+14.1%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 38334571.00 | -94.3% |
| 2023 | 673622000.00 | +2510.5% |
| 2022 | 25803889.00 | 0.0% |
| 2021 | 25803889.00 | - |